ARE FUNGAL BIOMARKERS USEFUL IN TREATING CANDIDA?

Saad Nseir sits down with icTV to discuss the encouraging results from his recently published randomised control trial, which examined the use of a biomarker strategy for early discontinuation of empirical antifungal treatment in critically ill patients. Findings from this trial were presented for the first time publicly during the Clinical Trials Session at LIVES 2017 in Vienna.

Read the article in Intensive Care Medicine HERE.